M&A was the universal prescription for the medical industry in 1998 as acquisition dollar volumes hit record levels. For some, the dealmaking further separates the haves and have-nots. For others, it's an addictive drug for coping with chronic insufficiency syndrome. But for nearly everyone who's using it, M&A is the easiest, if not always an effective, answer to the increasingly intractable problem of growth.
by Roger Longman
All roads in 1998, it sometimes seemed, led to M&A.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
